David O. Watson - Net Worth and Insider Trading

David O. Watson Net Worth

The estimated net worth of David O. Watson is at least $6 Million dollars as of 2024-11-13. David O. Watson is the General Counsel of Apellis Pharmaceuticals Inc and owns about 194,095 shares of Apellis Pharmaceuticals Inc (APLS) stock worth over $6 Million. Details can be seen in David O. Watson's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David O. Watson has not made any transactions after 2024-02-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of David O. Watson

David O. Watson Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David O. Watson owns 1 companies in total, including Apellis Pharmaceuticals Inc (APLS) .

Click here to see the complete history of David O. Watson’s form 4 insider trades.

Insider Ownership Summary of David O. Watson

Ticker	Comapny	Transaction Date	Type of Owner
APLS	Apellis Pharmaceuticals Inc	2024-02-12	General Counsel

David O. Watson Latest Holdings Summary

David O. Watson currently owns a total of 1 stock. David O. Watson owns 194,095 shares of Apellis Pharmaceuticals Inc (APLS) as of February 12, 2024, with a value of $6 Million.

Latest Holdings of David O. Watson

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
APLS	Apellis Pharmaceuticals Inc	2024-02-12	194,095	29.26	5,679,220

Holding Weightings of David O. Watson

David O. Watson Form 4 Trading Tracker

According to the SEC Form 4 filings, David O. Watson has made a total of 13 transactions in Apellis Pharmaceuticals Inc (APLS) over the past 5 years, including 0 buys and 13 sells. The most-recent trade in Apellis Pharmaceuticals Inc is the sale of 781 shares on February 12, 2024, which brought David O. Watson around $52,928.

Insider Trading History of David O. Watson

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David O. Watson Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

David O. Watson Ownership Network

Ownership Network List of David O. Watson

No Data

Ownership Network Relation of David O. Watson

David O. Watson Owned Company Details

What does Apellis Pharmaceuticals Inc do?

Who are the key executives at Apellis Pharmaceuticals Inc?

David O. Watson is the General Counsel of Apellis Pharmaceuticals Inc. Other key executives at Apellis Pharmaceuticals Inc include See Remarks James George Chopas , Chief Operating Officer Pascal Deschatelets , and Chief Financial Officer Timothy Eugene Sullivan .

Apellis Pharmaceuticals Inc (APLS) Insider Trades Summary

Over the past 18 months, David O. Watson made 6 insider transaction in Apellis Pharmaceuticals Inc (APLS) with a net sale of 22,526. Other recent insider transactions involving Apellis Pharmaceuticals Inc (APLS) include a net sale of 296,688 shares made by Pascal Deschatelets , a net sale of 463,087 shares made by Cedric Francois , and a net sale of 102,839 shares made by Timothy Eugene Sullivan .

In summary, during the past 3 months, insiders sold 37,742 shares of Apellis Pharmaceuticals Inc (APLS) in total and bought 0 shares, with a net sale of 37,742 shares. During the past 18 months, 1,263,451 shares of Apellis Pharmaceuticals Inc (APLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,263,451 shares.

Apellis Pharmaceuticals Inc (APLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Apellis Pharmaceuticals Inc Insider Transactions

No Available Data

David O. Watson Mailing Address

Above is the net worth, insider trading, and ownership report for David O. Watson. You might contact David O. Watson via mailing address: 6400 Westwind Way, Suite A, Crestwood Ky 40014.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.